Skip to main content
. 2018 Jan 1;9(1):148–156. doi: 10.7150/jca.22246

Table 2.

The correlation between clinicopathologic characters and FIB and FC-score (training cohort)

Characters FC-score
0 1 2 P-value
all patients 386 176 54
Gender, male/female 66/320 30/146 6/48 0.53
Age, <60/≥60 220/166 89/87 34/20 0.193
HBsAg,
negative/positive 53/333 40/136 7/47 0.022
AFP
<400/≥400 ng/mL 282/104 123/53 30/24 0.029
TBIL
<20/≥20 µmol/L 352/34 162/14 44/10 0.05
GGT, <45/≥45 U/L 178/208 61/115 9/45 <0.001
ALT, <50/≥50 U/L 304/82 148/28 43/11 0.333
ALB, <35/≥35g/L 12/374 3/173 6/48 0.003
CRP, <10/≥10mg/L 386/0 163/13 0/54 <0.001
PLT
<200/≥200 10^9/L 341/45 136/40 32/22 <0.001
N,<6.3/≥6.3 10^9/L 353/33 161/15 38/16 <0.001
L,<3.2/≥3.2 10^9/L 371/15 160/16 49/5 0.027
M,<0.6/≥0.6 10^9/L 311/75 114/62 14/40 <0.001
cirrhosis,no/yes 72/314 61/115 23/31 <0.001
tumor number,
single/multiple 340/46 144/32 49/5 0.083
tumor throbus
no/yes 373/13 162/14 42/12 <0.001
tumor capsule
no/yes 260/126 103/73 31/23 0.074
tumor size
<5/≥5cm 266/120 83/93 11/43 <0.001
LNM
no/yes 384/2 176/0 52/2 0.011
MVI, no/yes 303/83 120/56 27/27 <0.001
differentiation,
I-II/III-IV 271/115 119/57 31/23 0.161
IBS, 0/1 219/167 82/94 21/33 0.005
GPS, 0/1/2 367/19/0 163/11/2 5/43/6 <0.001
IBI,0/1/2 12/374/0 1/166/89 0/11/43 <0.001
FC-score,0/1/2
BCLC, A/B/C 301/74/11 93/72/12 8/40/6 <0.001
CLIP, 0/1-3/4-6 235/150/1 85/90/1 17/32/5 <0.001

APF, alpha fetal protein; FIB, fibrinogen; PLT, platelet; LNM, lymph node metastasis; MVI, microvascular invasion; IBS, Inflammation based score; GPS, Glasgow Prognostic Score; IBI, inflammation based index; FC-score, fibrinogen and C-reactive protein score; BCLC, Barcelona Clinic Liver Cancer staging system; CLIP, Cancer Liver Italian Program.